LD-2 disclosure · 2nd Quarter - Report

TEVA PHARMACEUTICALS USA INC

via TEVA PHARMACEUTICALS USA, INC.

2nd Quarter (Apr 1 - June 30) · 2025Posted Jul 17, 2025Filing document ↗LDA record ↗

Expenses$1.4Mself-filed spend

Client

2 issues

Health Issues
Use of Section viii statements in pharmaceutical labeling. FDAs approval of over-the-counter naloxone nasal spray. Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and legislation to reform pharmacy benefit managers. Patent reform legislation. Proposals related to drug shortages. Reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA).
LobbyistsCOLMAN BRENDAN RAGAN · MICHAEL BRZICA · BEENA S PATEL
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS) · Homeland Security, Dept of (DHS)
Tariff (miscellaneous tariff bills)
A joint resolution terminating the national emergency declared to impose duties on articles imported from Canada (S.J.Res.37).
LobbyistsMICHAEL BRZICA · BEENA S PATEL
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · U.S. Trade Representative (USTR) · Commerce, Dept of (DOC) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)

LD-2 disclosure · 2nd Quarter - Report

via TEVA PHARMACEUTICALS USA, INC.

2nd Quarter (Apr 1 - June 30) · 2025Posted Jul 17, 2025Filing document ↗LDA record ↗

Expenses$1.4Mself-filed spend

2 issues

Health Issues
Use of Section viii statements in pharmaceutical labeling. FDAs approval of over-the-counter naloxone nasal spray. Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and legislation to reform pharmacy benefit managers. Patent reform legislation. Proposals related to drug shortages. Reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA).
LobbyistsCOLMAN BRENDAN RAGAN · MICHAEL BRZICA · BEENA S PATEL
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS) · Homeland Security, Dept of (DHS)
Tariff (miscellaneous tariff bills)
A joint resolution terminating the national emergency declared to impose duties on articles imported from Canada (S.J.Res.37).
LobbyistsMICHAEL BRZICA · BEENA S PATEL
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · U.S. Trade Representative (USTR) · Commerce, Dept of (DOC) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)